Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007657675> ?p ?o ?g. }
- W2007657675 endingPage "1629" @default.
- W2007657675 startingPage "1623" @default.
- W2007657675 abstract "A rat spinal cord model was used to evaluate the effects of boron neutron capture irradiation on the central nervous system (CNS), using a range of doses of the boron delivery agent p-boronophenylalanine (BPA). Three doses of BPA 700, 1000 and 1600 mg kg(-1) were used to establish the biodistribution of boron-10 (10B) in blood, spinal cord and brain over a 3-h period after intraperitoneal (i.p.) administration. At the lowest dose of BPA used, blood 10B levels remained relatively stable over the 3-h sampling period. With the two higher doses of BPA, blood 10B concentrations were greatest at 1 h after BPA administration, and thereafter exhibited a biphasic clearance profile. The largest decline in blood 10B levels occurred between 1 and 2 h after i.p. injection and was most pronounced (approximately 45%) in the highest BPA dose group. Considered overall, 10B concentrations were marginally lower in the spinal cord than in the brain. Levels of 10B in both of these organs showed a slow but progressive increase with time after administration of BPA. The 10B concentration ratio for blood relative to CNS tissue increased with BPA dosage and reached a peak value of approximately 10:1 in the highest BPA dose group, at 1 h after i.p. injection. However, at 3 h after injection the 10B concentration ratios had decreased to approximately 3:1 in all of the BPA dose groups. After irradiation with thermal neutrons in combination with BPA at blood 10B concentrations of approximately 42 and approximately 93 microg g(-1), myelopathy developed after latent intervals of 20.0 +/- 0.6 and 20.0 +/- 1.2 weeks respectively. ED50 values (+/- s.e.) for the incidence of myelopathy were calculated from probit-fitted curves, and were 17.5 +/- 0.7 and 25.0 +/- 0.6 Gy after irradiation with thermal neutrons at blood 10B levels of approximately 42 and approximately 93 microg g(-1) respectively. The compound biological effectiveness (CBE) factor values, estimated from these data, were 0.67 +/- 0.23 and 0.48 +/- 0.18 respectively. This compared with a previous estimate of 0.88 +/- 0.14 at a blood 10B concentration of approximately 19 microg g(-1). It was concluded that the value of the CBE factor was not influenced by the level of 10B in the blood, but by the blood:CNS 10B concentration ratio. In effect, the CBE factor decreases as the concentration ratio increases. Simulations using boron neutron capture therapy (BNCT) treatment planning software indicate a significant therapeutic advantage could be obtained in moving to higher BPA doses than those in current clinical use." @default.
- W2007657675 created "2016-06-24" @default.
- W2007657675 creator A5005241307 @default.
- W2007657675 creator A5040656724 @default.
- W2007657675 creator A5041336753 @default.
- W2007657675 creator A5052650152 @default.
- W2007657675 creator A5082821373 @default.
- W2007657675 creator A5085724583 @default.
- W2007657675 date "1997-12-01" @default.
- W2007657675 modified "2023-10-10" @default.
- W2007657675 title "Central nervous system tolerance to boron neutron capture therapy with p-boronophenylalanine" @default.
- W2007657675 cites W1586467735 @default.
- W2007657675 cites W1970556497 @default.
- W2007657675 cites W1973795867 @default.
- W2007657675 cites W1977573815 @default.
- W2007657675 cites W1992133515 @default.
- W2007657675 cites W1996863402 @default.
- W2007657675 cites W2018690980 @default.
- W2007657675 cites W2029200505 @default.
- W2007657675 cites W2041867986 @default.
- W2007657675 cites W2046637869 @default.
- W2007657675 cites W2063847863 @default.
- W2007657675 cites W2070068475 @default.
- W2007657675 cites W2095424297 @default.
- W2007657675 cites W2111695740 @default.
- W2007657675 cites W2151051629 @default.
- W2007657675 cites W2155460816 @default.
- W2007657675 cites W2162091746 @default.
- W2007657675 cites W2170414057 @default.
- W2007657675 cites W2218007905 @default.
- W2007657675 cites W2298383921 @default.
- W2007657675 cites W573457 @default.
- W2007657675 doi "https://doi.org/10.1038/bjc.1997.607" @default.
- W2007657675 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2228217" @default.
- W2007657675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9413952" @default.
- W2007657675 hasPublicationYear "1997" @default.
- W2007657675 type Work @default.
- W2007657675 sameAs 2007657675 @default.
- W2007657675 citedByCount "35" @default.
- W2007657675 countsByYear W20076576752012 @default.
- W2007657675 countsByYear W20076576752013 @default.
- W2007657675 countsByYear W20076576752016 @default.
- W2007657675 countsByYear W20076576752017 @default.
- W2007657675 countsByYear W20076576752018 @default.
- W2007657675 countsByYear W20076576752021 @default.
- W2007657675 countsByYear W20076576752022 @default.
- W2007657675 countsByYear W20076576752023 @default.
- W2007657675 crossrefType "journal-article" @default.
- W2007657675 hasAuthorship W2007657675A5005241307 @default.
- W2007657675 hasAuthorship W2007657675A5040656724 @default.
- W2007657675 hasAuthorship W2007657675A5041336753 @default.
- W2007657675 hasAuthorship W2007657675A5052650152 @default.
- W2007657675 hasAuthorship W2007657675A5082821373 @default.
- W2007657675 hasAuthorship W2007657675A5085724583 @default.
- W2007657675 hasBestOaLocation W20076576752 @default.
- W2007657675 hasConcept C112705442 @default.
- W2007657675 hasConcept C118552586 @default.
- W2007657675 hasConcept C126322002 @default.
- W2007657675 hasConcept C134018914 @default.
- W2007657675 hasConcept C177322064 @default.
- W2007657675 hasConcept C185592680 @default.
- W2007657675 hasConcept C202751555 @default.
- W2007657675 hasConcept C2777807558 @default.
- W2007657675 hasConcept C2780775167 @default.
- W2007657675 hasConcept C529278444 @default.
- W2007657675 hasConcept C55493867 @default.
- W2007657675 hasConcept C71924100 @default.
- W2007657675 hasConcept C98274493 @default.
- W2007657675 hasConceptScore W2007657675C112705442 @default.
- W2007657675 hasConceptScore W2007657675C118552586 @default.
- W2007657675 hasConceptScore W2007657675C126322002 @default.
- W2007657675 hasConceptScore W2007657675C134018914 @default.
- W2007657675 hasConceptScore W2007657675C177322064 @default.
- W2007657675 hasConceptScore W2007657675C185592680 @default.
- W2007657675 hasConceptScore W2007657675C202751555 @default.
- W2007657675 hasConceptScore W2007657675C2777807558 @default.
- W2007657675 hasConceptScore W2007657675C2780775167 @default.
- W2007657675 hasConceptScore W2007657675C529278444 @default.
- W2007657675 hasConceptScore W2007657675C55493867 @default.
- W2007657675 hasConceptScore W2007657675C71924100 @default.
- W2007657675 hasConceptScore W2007657675C98274493 @default.
- W2007657675 hasIssue "12" @default.
- W2007657675 hasLocation W20076576751 @default.
- W2007657675 hasLocation W20076576752 @default.
- W2007657675 hasLocation W20076576753 @default.
- W2007657675 hasLocation W20076576754 @default.
- W2007657675 hasOpenAccess W2007657675 @default.
- W2007657675 hasPrimaryLocation W20076576751 @default.
- W2007657675 hasRelatedWork W1969303838 @default.
- W2007657675 hasRelatedWork W1993687774 @default.
- W2007657675 hasRelatedWork W2359190752 @default.
- W2007657675 hasRelatedWork W2385718423 @default.
- W2007657675 hasRelatedWork W2405439227 @default.
- W2007657675 hasRelatedWork W2600864379 @default.
- W2007657675 hasRelatedWork W2901041008 @default.
- W2007657675 hasRelatedWork W3030179994 @default.
- W2007657675 hasRelatedWork W3148766288 @default.
- W2007657675 hasRelatedWork W3032237923 @default.